164 related articles for article (PubMed ID: 2808214)
1. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():31-45. PubMed ID: 2808214
[TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of meropenem against clinical isolates obtained in Canada.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
[TBL] [Abstract][Full Text] [Related]
5. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial in vitro-activity of meropenem against 200 clinical isolates in comparison to 11 selected antibiotics.
Lang C; Beuth J; Ko HL; Tunggal L; Pulverer G
Zentralbl Bakteriol; 1992 Dec; 277(4):485-92. PubMed ID: 1303691
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
[TBL] [Abstract][Full Text] [Related]
8. Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex.
Inderlied CB; Lancero MG; Young LS
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():85-99. PubMed ID: 2808217
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial properties of meropenem towards clinical isolates, beta-lactamase producers and laboratory mutants.
Wiedemann B; Zühlsdorf M
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():197-205. PubMed ID: 2681124
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.
Edwards JR; Turner PJ; Wannop C; Withnell ES; Grindey AJ; Nairn K
Antimicrob Agents Chemother; 1989 Feb; 33(2):215-22. PubMed ID: 2655530
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
Pitkin DH; Sheikh W; Nadler HL
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
[TBL] [Abstract][Full Text] [Related]
12. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
Watt B; Naden M
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro activity of PD127,391, a new quinolone.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1988 Aug; 22(2):135-41. PubMed ID: 3182416
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
Bauernfeind A; Jungwirth R; Schweighart S
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of meropenem and interactions with other antibiotics.
Ferrara A; Grassi G; Grassi FA; Piccioni PD; Gialdroni Grassi G
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():239-50. PubMed ID: 2808210
[TBL] [Abstract][Full Text] [Related]
16. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.
Sanders CC; Sanders WE; Thomson KS; Iaconis JP
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():187-96. PubMed ID: 2808207
[TBL] [Abstract][Full Text] [Related]
17. Activity of meropenem, against gram-positive bacteria.
Kayser FH; Morenzoni G; Strässle A; Hadorn K
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
[TBL] [Abstract][Full Text] [Related]
18. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.
Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):157-63. PubMed ID: 9327242
[TBL] [Abstract][Full Text] [Related]
19. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.
Piddock LJ; Turner HL
Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1186-91. PubMed ID: 1291320
[TBL] [Abstract][Full Text] [Related]
20. Activity of imipenem on aerobic bacteria.
Acar JF; Goldstein FW; Kitzis MD; Gutmann L
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():37-45. PubMed ID: 6421793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
